A Phase Ib Multi-Cohort Trial of MK-3475 in Subjects with Hematologic Malignancies

Type of Cancer
Lung

Site
Hackensack

Sponsor
Merck & Co., Inc.

Protocol Number
MK-3475-013

To Learn More Call
201-510-0910